Your browser doesn't support javascript.
loading
Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report.
Umekawa, Motoyuki; Saito, Keita; Shinya, Yuki; Hasegawa, Hirotaka; Kawashima, Mariko; Teranishi, Yu; Katano, Atsuto; Ikemura, Masako; Saito, Nobuhito.
  • Umekawa M; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Saito K; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Shinya Y; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. yukishinya6155@gmail.com.
  • Hasegawa H; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Kawashima M; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Teranishi Y; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Katano A; Department of Radiology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.
  • Ikemura M; Department of Pathology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.
  • Saito N; Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Acta Neurochir (Wien) ; 165(1): 221-224, 2023 01.
Article en En | MEDLINE | ID: mdl-36241743
ABSTRACT
Lacrimal gland pleomorphic adenomas (LGPAs) are common, benign, and intraorbital tumours that cause exophthalmos, ptosis, and visual disturbances. The curative treatment for LGPAs is gross total resection, and radiotherapy is considered adjunctive for recurrence or an alternative for inoperable LGPAs. Stereotactic radiosurgery (SRS) can be used for precise delivery of high radiation doses to the tumour, crucial in the treatment of intra-and extracranial neoplasms. Here, we present a 95-year-old woman who had a rapidly growing, recurrent LGPA and was successfully treated with SRS. The tumour was controlled without any adverse events over 21 months following SRS. SRS is a potential alternative treatment for recurrent LGPA.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiocirugia / Adenoma Pleomórfico / Neoplasias del Ojo / Aparato Lagrimal / Enfermedades del Aparato Lagrimal Límite: Aged80 / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radiocirugia / Adenoma Pleomórfico / Neoplasias del Ojo / Aparato Lagrimal / Enfermedades del Aparato Lagrimal Límite: Aged80 / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article